Aquaporumab: An Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica

Update Item Information
Identifier 20120213_nanos_sciplatform_03
Title Aquaporumab: An Anti-Aquaporin-4 Monoclonal Antibody Blocker Therapy for Neuromyelitis Optica
Creator Bennett, Jeffrey; Tradtrantip, Lukmanee; Zhang, Hua; Saadoun, Samira; Phuan, Puay-Wah; Lam, Chiwah; Papadopoulos, Marios; Verkman, Alan
Subject Neuromyelitis optica; aquaporin-4; therapy; monoclonal antibody
Description Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that predominantly affects the optic nerves and spinal cord. Circulating autoantibodies (NMO-IgG) against the astrocyte water channel aquaporin-4 (AQP4) cause complement- and cell-mediated astrocyte damage with consequent neuroinflammation and demyelination.
Date 2012-02-13
Language eng
Format application/pdf
Format Creation application/pdf
Type Text
Source 2012 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2012: Scientific Platform Presentations (Session I)
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2012. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6dn7bjr
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Secondary Wong, Agnes M F; Subramanian, Prem S
Setname ehsl_novel_nam
ID 181984
Reference URL https://collections.lib.utah.edu/ark:/87278/s6dn7bjr
Back to Search Results